ANH Lawsuit Against FDA Homeopathy Guidance Gains Media Attention
Listen to the audio version of this article: A recent HBW Insight article centered on an interview with ANH-USA General Counsel, Jonathan Emord, Esq., spotlighted our ongoing legal battle with the FDA over its restrictive 2022 final guidance on homeopathic products. The FDA’s move made in 2022 under the Biden Administration effectively revoked the long-standing […]